Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm.

Keller, Alana L; Sherbenou, Daniel W; Forsberg, Peter A; Mark, Tomer M

Keller, Alana L; Sherbenou, Daniel W; Forsberg, Peter A; Mark, Tomer M.

Afiliación

Keller AL; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Sherbenou DW; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Forsberg PA; Comprehensive Cancer Center, University of Colorado, Aurora, CO, United States.
Mark TM; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Front Oncol ; 12: 925818, 2022.

Article en En | MEDLINE | ID: mdl-35814431

Palabras clave

B cell maturation antigen; CAR T cell therapy; T cells; bispecific antibodies; immunotherapy; myeloma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos